Pharmacological evaluation of rat dorsal root ganglion neurons as an in vitro model for diabetic neuropathy

Journal of Pain Research

Volumn 4, Issue , 2011, Pages 55-65

  Peeraer, Eve ^a,b   van Lutsenborg, An ^c   Verheyen, An ^a,d   de Jongh, Raf ^e   Nuydens, Rony ^a   Meert, Theo F ^a,b  

^a JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

^b HASSELT UNIVERSITY   (Belgium)

^c FREE UNIVERSITY OF BRUSSELS   (Belgium)

^d UNIVERSITY OF LEUVEN   (Belgium)

^e DEPARTMENT OF CARDIOLOGY   (Belgium)

Author keywords

Activating transcription factor 3; Anticonvulsants; Diabetic peripheral neuropathy; Dorsal root ganglion; Glial cell line derived neurotrophic factor

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; CARBAMAZEPINE; GABAPENTIN; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STRESS; CONTROLLED STUDY; DIABETIC NEUROPATHY; DRUG EFFECT; DRUG EFFICACY; EX VIVO STUDY; HYPERALGESIA; HYPERGLYCEMIA; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; MALE; NERVE CELL CULTURE; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; RAT; SPINAL CORD NERVE CELL; SPINAL GANGLION;

EID: 79953130368     PISSN: 11787090     EISSN: None     Source Type: Journal    
DOI: 10.2147/JPR.S15452     Document Type: Article

References (48)

1. Pirart J. Diabetes mellitus and its degenerative complications: A prospective study of 4,400 patients observed between 1947 and 1973. Diabetes Care. 1978;1:168-188.
2. Thomas PK, Tomlinson DR. Diabetic and hypoglycaemic neuropathy. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF, editors. Peripheral Neuropathy. Philadelphia, PA: WB Saunders Co; 1992.
3. Yagihashi S. Pathology and pathogenetic mechanisms of diabetic neuropathy. Diabetes Metab Rev. 1996;11:193-225.
4. The Diabetes Control and Complications Trial Research group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
5. The Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Intern Med. 1995;122:561-568.
6. Sima AAF. New insights into the metabolic and molecular basis for diabetic neuropathy. Cell Mol Life Sci. 2003;60:2445-2464.
7. Leinninger GM, Vincent AM, Feldman EL. The role of growth factors in diabetic peripheral neuropathy. J Peripher Nerv Syst. 2004;9: 26-53.
8. Russell JW, Windebank AJ. Electrophysiological and pathological characteristics of suramin induced neuropathy. Neurology. 1993; 43:A174.
9. Russell JW, Sullivan KA, Windebank AJ, Herrmann DN, Feldman EL. Neurons undergo apoptosis in animal and cell culture models of diabetes. Neurobiol Dis. 1999;6:347-363.
10. Backonja M. Use of anticonvulsants for the treatment of neuropathic pain. Neurology. 2002;59:S14-S17.
11. Jensen TS. Anticonvulsants in neuropathic pain: Rationale and clinical evidence. Eur J Pain. 2002;6:61-68.
12. Lin LH, Doherty DH, Lile JD, Bektesh S, Collins F. GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science. 1993;260:1130-1132.
13. Henderson CE, Phillips HS, Pollock RA, et al. GDNF: A potent survival factor for motoneurons present in peripheral nerve and muscle. Science. 1994;266:1062-1064.
14. Molliver DC, Wright DE, Leitner ML, et al. IB4-binding DRG neurons switch from NGF to GDNF dependence in early postnatal life. Neuron. 1997;19:849-861.
15. Dickernson AH, Matthews EA, Suzuki R. Neurobiology of neuropathic pain: Mode of action of anticonvulsants. Eur J Pain. 2002;6:51-60.
16. Curran MP, Wagstaff AJ. Gabapentin in postherpetic neuralgia. CNS Drugs. 2003;17:975-982.
17. Chen BP, Wolfgang CD, Hai T. Analysis of ATF3, a transcription factor induced by physiological stresses and modulated by gadd153/chop10. Mol Cell Biol. 1996;16:1157-1168.
18. Yin T, Sandhu G, Wolfgang CD, et al. Tissue-specific pattern of stress kinase activation in ischemic/reperfused heart and kidney. J Biol Chem. 1997;272:19943-19950.
19. Hai T, Wolfgang CD, Marsee DK, Allen AE, Sivaprasad U. ATF3 and stress responses. Gene Expression. 1999;7:321-335.
20. Tsujino H, Kondo E, Fukuoka T, et al. Activating transcription factor 3 (ATF3) induction by axotomy in sensory and motoneurons: A novel neuronal marker of nerve injury. Mol Cell Neurosci. 2000;15: 170-182.
21. Hai T, Curran T. Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc Natl Acad Sci U S A. 1991;88:3720-3724.
22. Obata K, Yamanaka H, Fukuoka T, et al. Contribution of injured and uninjured dorsal root ganglion neurons to pain behavior and the changes in gene expression following chronic constriction injury of the sciatic nerve in rats. Pain. 2003;101:65-77.
23. Huang WL, Robson M, Liu C, et al. Spinal cord compression and dorsal root injury cause up-regulation of activating transcription factor-3 in large-diameter dorsal root ganglion neurons. Eur J Neurosci. 2006;23: 273-278.
24. Shortland PJ, Baytug B, Krzyzanowska A, McMahon SB, Priestley JV, Averill S. ATF3 expression in L4 dorsal root ganglion neurons after L5 spinal nerve transaction. Eur J Neurosci. 2006;23:265-373.
25. Saito H, Dahlin LB. Expression of ATF3 and axonal outgrowth are impaired after delayed nerve repair. BMC Neurosci. 2008;9:88.
26. Bráz JM, Basbaum AI. Differential ATF3 expression in dorsal root ganglion neurons reveal the profile of primary afferents engaged by diverse noxious chemical stimuli. Pain. 2010;150:290-301.
27. Baudet C, Mikaels A, Westphal H, Johansen J, Johansen TE, Ernfors P. Positive and negative interactions of GDNF, NTN and ART in developing sensory neuron subpopulations, and their collaboration with neurotrophins. Development. 2000;127:4335-4344.
28. Madduri S, Papaloïzos M, Gander B. Synergistic effect of GDNF and NGF on axonal branching and elongation in vitro. Neurosci Res. 2009; 65:88-97.
29. Perucca E. Is there a role for therapeutic drug monitoring of new anticonvulsants? Clin Pharmacokinet. 2000;38:191-204.
30. Gumy LF, Bampton ETW, Tolkovsky AM. Hyperglycaemia inhibits Schwann cell proliferation and migration and restricts regeneration of axons and Schwann cells from adult murine DRG. Mol Cell Neurosci. 2008;37:298-311.
31. Zherebitskaya E, Akude E, Smith DR, Fernyhough P. Development of selective axonopathy in adult sensory neurons isolated from diabetic rats: Role of glucose-induced oxidative stress. Diabetes. 2009;58: 1356-1364.
32. Vincent AM, Olzmann JA, Brownlee M, Sivitz WI, Russell JW. Uncoupling proteins prevent glucose-induced neuronal oxidative stress and programmed cell death. Diabetes. 2004;53:726-734.
33. Vincent AM, Russell JW, Low P, Feldman EL. Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr Rev. 2004;25:612-628.
34. Vincent AM, McLean LL, Backus C, Feldman EL. Short-term hyperglycemia produces oxidative damage and apoptosis in neurons. FASEB J. 2005;19:638-640.
35. Russell JW, Golovoy D, Vincent AM, et al. High glucose-induced oxidative stress and mitochondrial dysfunction in neurons. FASEB J. 2002;16:1738-1748.
36. Lindsay RM. Nerve growth factors (NGF, BDNF) enhance axonal regeneration but are not required for survival of adult sensory neurons. J Neurosci. 1988;8:2394-2405.
37. Pearson AG, Gray CW, Pearson JF, Greenwood JM, During MJ, Dragunow M. ATF3 enhances c-Jun-mediated neurite sprouting. Mol Brain Res. 2003;120:38-45.
38. Lindwall C, Kanje M. The Janus role of c-jun: Cell death versus survival and regeneration of neonatal sympathetic and sensory neurons. Exp Neurol. 2005;196:184-194.
39. Seijffers R, Allchorne AJ, Woolf CJ. The transcription factor ATF-3 promotes neurite outgrowth. Mol Cell Neurosci. 2006;32:143-154.
40. Hoybergs YMJJ, Meert TF. The effect of low-dose insulin on mechanical sensitivity and allodynia in type I diabetes neuropathy. Neurosci Lett. 2007;417:149-154.
41. Srinivasan S, Stevens M, Wiley JW. Diabetic peripheral neuropathy. Evidence for apoptosis and associated mitochondrial dysfunction. Diabetes. 2000;49:1932-1938.
42. Wright DE, Ryals JM, McCarson KE, Christianson JA. Diabetes-induced expression of activating transcription factor 3 in mouse primary sensory neurons. J Peripher Nerv Syst. 2004;9:242-254.
43. Aoki Y, An HS, Takahashi K, et al. Axonal growth potential of lumbar dorsal root ganglion neurons in an organ culture system. Spine. 2007;32: 857-863.
44. Dahlin LB, Stenberg L, Luthman H, Thomsen NOB. Nerve compression induces activating transcription factor 3 in neurons and Schwann cells in diabetic rats. Neuroreport. 2008;19:987-990.
45. Akkina SK, Patterson CL, Wright DE. GDNF rescues nonpeptidergic unmyelinated primary afferents in streptozotocin-treated diabetic mice. Exp Neurol. 2001;167:173-182.
46. Christianson JA, Riekhof JT, Wright DE. Restorative effects of neurotrophin treatment on diabetes-induced cutaneous axon loss in mice. Exp Neurol. 2003;179:188-199.
47. Averill S, Michael GJ, Shortland PJ, et al. NGF and GDNF ameliorate the increase in ATF3 expression which occurs in dorsal root ganglion cells in response to peripheral nerve injury. Eur J Neurosci. 2004;19: 1437-1445.
48. Wang R, Guo W, Ossipov MH, Vanderah TW, Porreca F, Lai J. Glial cell line-derived neurotrophic factor normalizes neurochemical changes in injured dorsal root ganglion neurons and prevents the expression of experimental neuropathic pain. Neuroscience. 2003;121:815-824.